Lung deposition of inhaled alpha-1-proteinase inhibitor (alpha 1-PI) - problems and experience of alpha1-PI inhalation therapy in patients with hereditary alpha1-PI deficiency and cystic fibrosis
about
Expanding the clinical indications for α(1)-antitrypsin therapyα1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke.Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies.
P2860
Lung deposition of inhaled alpha-1-proteinase inhibitor (alpha 1-PI) - problems and experience of alpha1-PI inhalation therapy in patients with hereditary alpha1-PI deficiency and cystic fibrosis
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Lung deposition of inhaled alp ...... deficiency and cystic fibrosis
@en
Lung deposition of inhaled alpha-1-proteinase inhibitor
@nl
type
label
Lung deposition of inhaled alp ...... deficiency and cystic fibrosis
@en
Lung deposition of inhaled alpha-1-proteinase inhibitor
@nl
prefLabel
Lung deposition of inhaled alp ...... deficiency and cystic fibrosis
@en
Lung deposition of inhaled alpha-1-proteinase inhibitor
@nl
P2860
P921
P1476
Lung deposition of inhaled alp ...... deficiency and cystic fibrosis
@en
P2093
R Siekmeier
P2860
P304
P407
P478
15 Suppl 2
P577
2010-11-01T00:00:00Z
2010-11-04T00:00:00Z